These studies support the role of autophagy and EMT in oxaliplatin resistance and provide a potential explanation for the present results, suggesting that the downregulation of EVA1A by miR-125b could inhibit autophagy and EMT, thereby contributing to the reversal of oxaliplatin resistance in HCC. Here, EVA1A is linked to hepatocellular carcinoma.